Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: A systematic review

Figure 3 Meta-analysis of three trials that used mosapride as combined therapy with proton pump inhibitor compared with placebo in gastroesophageal reflux disease, a fixed-effects model was used and pooled relative rate was the measure of effect size. I², total variation across studies that is attributable to heterogeneity rather than to chance; PRR: Pooled relative rate.